Pfizer will test its COVID-19 vaccine in a larger group of children between 6 months and 12 years old after choosing a lower dose than it administered in an earlier stage of the trial, The New York ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback